- Home
- GOVX vs AEON Comparison
GOVX vs AEON Comparison
Compare GOVX & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- AEON
- Stock Information
- Founded
- GOVX 2001
- AEON N/A
- Country
- GOVX United States
- AEON United States
- Employees
- GOVX N/A
- AEON N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- GOVX Health Care
- AEON Health Care
- Exchange
- GOVX Nasdaq
- AEON Nasdaq
- Market Cap
- GOVX 7.6M
- AEON 8.0M
- IPO Year
- GOVX N/A
- AEON N/A
- Fundamental
- Price
- GOVX $0.68
- AEON $0.77
- Analyst Decision
- GOVX Strong Buy
- AEON Strong Buy
- Analyst Count
- GOVX 3
- AEON 1
- Target Price
- GOVX $10.67
- AEON $360.00
- AVG Volume (30 Days)
- GOVX 690.2K
- AEON 77.4K
- Earning Date
- GOVX 11-11-2025
- AEON 11-12-2025
- Dividend Yield
- GOVX N/A
- AEON N/A
- EPS Growth
- GOVX N/A
- AEON N/A
- EPS
- GOVX N/A
- AEON N/A
- Revenue
- GOVX $6,143,044.00
- AEON N/A
- Revenue This Year
- GOVX N/A
- AEON N/A
- Revenue Next Year
- GOVX N/A
- AEON N/A
- P/E Ratio
- GOVX N/A
- AEON N/A
- Revenue Growth
- GOVX 1943.07
- AEON N/A
- 52 Week Low
- GOVX $0.43
- AEON $0.38
- 52 Week High
- GOVX $3.88
- AEON $115.57
- Technical
- Relative Strength Index (RSI)
- GOVX 41.08
- AEON 52.68
- Support Level
- GOVX $0.65
- AEON $0.72
- Resistance Level
- GOVX $0.73
- AEON $0.81
- Average True Range (ATR)
- GOVX 0.04
- AEON 0.05
- MACD
- GOVX -0.00
- AEON 0.00
- Stochastic Oscillator
- GOVX 21.28
- AEON 67.91
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.